Darolutamide 300 mg trials for Prostate cancer

All Darolutamide 300 mg trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Darolutamide 300 mg for Prostate cancer

• ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
  NCT04916613 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 95 locations
• Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases
  NCT05116475 · Phase: Phase 3 · Ages: 18 Years to 120 Years · Sex: Male · 1 location
• Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
  NCT06276465 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 4 locations

Common questions

How many trials study Darolutamide 300 mg for Prostate cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.